Human Recombinant NDRG1 protein, His Tag (V2LY-0526-LY5710)

Go to compare Compare Online Inquiry
Request for COA
Datasheet Target References Q & As Review & reward Protocols Associated Products

Basic Information

Expressed Host
E. coli
Protein Species
Human
Tag
His Tag
Protein Construction
This product is Human Recombinant NDRG1 protein, His Tag consist of Amino Acid: 1-394 and predicts a molecular mass of 43.8 kDa.
Molecule Mass
43.8 kDa
Sequence
Amino Acid: 1-394
Species
Human

Formulations & Storage [For reference only, actual COA shall prevail!]

Purity
>85% as determined by SDS-PAGE
Endotoxin
Please contact us for more information.
Format
Lyophilized
Reconstitution
Allow the vial and reconstitution buffer to equilibrate to room temperature. Briefly centrifuge or tap down the vial to ensure that all lyophilized powder is collected at the bottom of the vial. For the reconstitution of this product, we recommend adding PBS or sterile water to achieve a final antibody concentration of 1 mg/mL. Allow the vial to reconstitute for 10-15 minutes at room temperature with gentle agitation. Avoid vigorous shaking that can cause foaming and antibody denaturation. Aliquot into volumes based on your experiment and store liquid protein at -20°C or -80°C for long time.
Buffer
Lyophilized from sterile PBS
Preservative
None
Storage
Samples are stable for up to twelve months from date of receipt at -20°C to -80°C. Store it under sterile conditions at -20°C to -80°C. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
More Infomation

Target

Full Name
N-Myc Downstream Regulated 1
Function
Stress-responsive protein involved in hormone responses, cell growth, and differentiation. Acts as a tumor suppressor in many cell types. Necessary but not sufficient for p53/TP53-mediated caspase activation and apoptosis. Has a role in cell trafficking, notably of the Schwann cell, and is necessary for the maintenance and development of the peripheral nerve myelin sheath. Required for vesicular recycling of CDH1 and TF. May also function in lipid trafficking. Protects cells from spindle disruption damage. Functions in p53/TP53-dependent mitotic spindle checkpoint. Regulates microtubule dynamics and maintains euploidy.
Biological Process
Cellular response to hypoxia Source: UniProtKB
DNA damage response, signal transduction by p53 class mediator Source: UniProtKB
Mast cell activation Source: Ensembl
Negative regulation of cell population proliferation Source: Ensembl
Peripheral nervous system myelin maintenance Source: Ensembl
Response to metal ion Source: ProtInc
Signal transduction Source: GO_Central
Cellular Location
Nucleus
Cytoskeleton
centrosome
cytosol
Plasma membrane
Cell membrane
Note: Mainly cytoplasmic but differentially localized to other regions. Associates with the plasma membrane in intestinal epithelia and lactating mammary gland. Translocated to the nucleus in a p53/TP53-dependent manner. In prostate epithelium and placental chorion, located in both the cytoplasm and in the nucleus. No nuclear localization in colon epithelium cells. In intestinal mucosa, prostate and renal cortex, located predominantly adjacent to adherens junctions. Cytoplasmic with granular staining in proximal tubular cells of the kidney and salivary gland ducts. Recruits to the membrane of recycling/sorting and late endosomes via binding to phosphatidylinositol 4-phosphate. Associates with microtubules. Colocalizes with TUBG1 in the centrosome. Cytoplasmic location increased with hypoxia. Phosphorylated form found associated with centromeres during S-phase of mitosis and with the plasma membrane.
Involvement in disease
Charcot-Marie-Tooth disease 4D (CMT4D):
A recessive demyelinating form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Demyelinating neuropathies are characterized by severely reduced nerve conduction velocities (less than 38 m/sec), segmental demyelination and remyelination with onion bulb formations on nerve biopsy, slowly progressive distal muscle atrophy and weakness, absent deep tendon reflexes, and hollow feet. By convention autosomal recessive forms of demyelinating Charcot-Marie-Tooth disease are designated CMT4.
PTM
Under stress conditions, phosphorylated in the C-terminal on many serine and threonine residues. Phosphorylated in vitro by PKA. Phosphorylation enhanced by increased intracellular cAMP levels. Homocysteine induces dephosphorylation. Phosphorylation by SGK1 is cell cycle dependent.

Deng, Z., & Richardson, D. R. (2023). The myc family and the metastasis suppressor NDRG1: targeting key molecular interactions with innovative therapeutics. Pharmacological Reviews, 75(5), 1007-1035.

Zhao, X., & Richardson, D. R. (2023). The role of the NDRG1 in the pathogenesis and treatment of breast cancer. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 188871.

Zhang, G., Qin, Q., Zhang, C., Sun, X., Kazama, K., Yi, B., ... & Sun, J. (2023). NDRG1 signaling is essential for endothelial inflammation and vascular remodeling. Circulation Research, 132(3), 306-319.

Joshi, V., Lakhani, S. R., & McCart Reed, A. E. (2022). NDRG1 in Cancer: A Suppressor, Promoter, or Both?. Cancers, 14(23), 5739.

Villodre, E. S., Hu, X., Eckhardt, B. L., Larson, R., Huo, L., Yoon, E. C., ... & Debeb, B. G. (2022). NDRG1 in aggressive breast cancer progression and brain metastasis. JNCI: Journal of the National Cancer Institute, 114(4), 579-591.

Chekmarev, J., Azad, M. G., & Richardson, D. R. (2021). The oncogenic signaling disruptor, NDRG1: Molecular and cellular mechanisms of activity. Cells, 10(9), 2382.

Yang, G., Huang, L., Jia, H., Aikemu, B., Zhang, S., Shao, Y., ... & Ma, J. (2021). NDRG1 enhances the sensitivity of cetuximab by modulating EGFR trafficking in colorectal cancer. Oncogene, 40(41), 5993-6006.

Lim, S. C., Geleta, B., Maleki, S., Richardson, D. R., & Kovačević, Ž. (2021). The metastasis suppressor NDRG1 directly regulates androgen receptor signaling in prostate cancer. Journal of Biological Chemistry, 297(6).

Park, K. C., Paluncic, J., Kovacevic, Z., & Richardson, D. R. (2020). Pharmacological targeting and the diverse functions of the metastasis suppressor, NDRG1, in cancer. Free Radical Biology and Medicine, 157, 154-175.

Villodre, E. S., Gong, Y., Hu, X., Huo, L., Yoon, E. C., Ueno, N. T., ... & Debeb, B. G. (2020). NDRG1 expression is an independent prognostic factor in inflammatory breast cancer. Cancers, 12(12), 3711.

Ask a question We look forward to hearing from you.
0 reviews or Q&As
Loading...
Have you used Human Recombinant NDRG1 protein, His Tag?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

online inquiry
Online Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.